Bradley Merrill Thompson Comments on FTC Charges Against Medical App Developer’s Advertising Claims – Media Coverage RoundupMultiple Publications January 21, 2015
Bradley Merrill Thompson, Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted in multiple publications regarding a recent FTC complaint against an app developer, charging that its app advertising made unsubstantiated claims of medical benefit.
Following is an excerpt from Reuters:
"We could well see FTC taking the primary enforcement role," said Bradley Merrill Thompson, a Washington D.C.-based attorney with the firm Epstein Becker & Green. That the FTC took action, rather than the U.S. Food and Drug Administration, represents an important shift, Thompson added.
MedCity News, 01/21/2015
mHealth News, 01/21/2015
HealthData Management, 01/21/2015
MobiHealth News, 01/20/2015